PharmaTalkRadio

Latest Episodes:

Podcast: From a Zimbabwean Village Kid to a PhD Regenerative Medicine Student Aug 30, 2018

Show notes

Can you imagine coming from a family of 21 kids in a small remote village in Africa with no running water or electricity and one day a snake bite changes your entire future and you end up a PhD student in WInston-Salem, NC? In this remarkable story, our guest Goodwell Nzou, PhD candidate in molecular medicine at the Institute at Wake Translation Science tells Valerie Bowling, Executive Director, the Conference Forum how he went from a village kid to an amputee to a band member that led him to a contest, a role in an Oscar winning documentary to a PhD candidate in a field that he hopes one day will allow him to grow back his own leg through regenerative medicine. Schools cited in the podcast include: Jairos Jiri Association King George VI Centre Wake Forest School of Medicine Guest: Goodwell Nzou, PhD candidate in molecular medicine at the Inst at Wake Translation Science Host: Valerie Bowling, Executive Director, PharmaTalk Radio and the Conference Forum

All of Us Research Program, a Nation-wide Initiative from the NIH Aug 17, 2018

Show notes

Podcast guest, Elise Felicione, who is currently a Scientific Collaborator at the Scripps Translational Science Institute is playing an integral role under the direction of Dr Eric Topol on a nation-wide initiative from the NIH. The initiative is called All Of Us, a US Precision Medicine program that aims to enroll a million Americans and follow them for 10 years, during which time participants will contribute biological, environmental, and lifestyle data. One-third of participants will participate virtually (not via a research site). The cohort will mirror the projected 2040 census. Individual pharma companies are never going to create cohorts like this, so the importance of this open source frame work that drug developers can tap into will be highly beneficial in serving the patient of the future. Discussion points include: What is the All Of Us Research Program?Why does this matter to biopharmaceutical companies?How far along is the program and how to get invovled?What are your biggest challenges?How can biopharmaceutical companies get involved? For more information on the All of Us program, visit: https://allofus.nih.gov/ Elise will be speaking at DPharm on September 26th and will also have an exhibit booth to answer any questions are All of Us. For information on DPharm taking place September 25-26, 2018 in Boston. For information, please visit, www.theconferenceforum.org Producer: Valerie Bowling, Executive Director, Pharma Talk Radio and DPharm

Reimagining Clinical Trials with Entrepreneur, Dr Ben Liu, CEO, Trialspark Aug 17, 2018

Show notes

During his graduate work, Dr Benjamine Liu observed the many bottlenecks that get in the way of clinical trials slowing the development of new treatments for patients. This challenge inspired him to launch Trialspark. Trialspark partners with doctors to create FDA compliant trial sites within their existing practices (like Airbnb), unlocking the 98% of patients and doctors not involved in trials today and democratizing access to research treatments. In this podcast discussion with Ben, we discuss how to reimagine clinical trials, entrepreneurism, the rise of Trialspark and reducing the barriers for patients and investigators. Ben will be speaking at DPharm on September 26th in Boston with Dr Ulo Palm, SVP Global Drug Development Operations, Allergan on a case study to scale more efficient clinical trials. For more information about Trialspark, visit www.trialspark.com For more information about DPharm visit www.theconferenceforum.org Producer: Valerie Bowling, Executive Director, Pharma Talk Radio and DPharm

Blockchain Opportunities for Patient Data Donation and Clinical Research Aug 16, 2018

Show notes

Patients are at the center of research and their data is the foundation for clinical innovation. However, significant barriers exist that inhibit the secure and efficient sharing of patient data. In this podcast, Craig Lipset, Head of Clinical Innovation, Pfizer, Munther Barra, Head of New Clinical Paradigm, Pfizer and Aditya Kudumala, Principal, Deloitte discuss blockchain as a catalyst to significantly change how we can access and use data to improve patient lives. Where is the patient data storm going? Discussion points include, but not limited to: Who owns my data and where it’s going?What are the interoperability challenges and progress?How can data be shared?How you can pull in your own health data?Where does blockchain fit in and how can it secure patient data? How blockchain gives us authentication without identification?Next steps? For more information on this topic and to get access to the Blockchain Opportunities for Patient Data Donation & Cinical Research, click here. Craig will be leading an entire section on the democratization of patient data at DPharm on September 25-26 in Boston.

DPharm Podcast: What to Expect at the 2018 Event in 8 Minutes Aug 16, 2018

Show notes

This 8 minute podcast gives you an overview on what to expect from the 8th annual DPharm conference. DPharm is the annual event in the US to get the best access to innovative ideas, especially disruptive ones, to advance clinical trials with a view to reducing the burden to patients and investigators. DPharm 2018 is dedicated to all things digital, data science, patient data ownership and new approaches to optimize clinical operation systems. DPharm is September 25-26 at the Boston Marriott Copley Place. Chaired by: Sylke Poehling, PhD, SVP and Global Head, Strategy, Portfolio & Clinical Operations, Pharma Research & Early Development, Roche Andreas Koester, MD, PhD, VP and Global Head, Janssen Clinical Innovation, Janssen Craig Lipset, MBA, Head of Clinical Innovation, Pfizer For more information visit www.theconferenceforum.org Producer: Valerie Bowling, Executive Director, DPharm

Mobile in Clinical Trials Podcast: 3 1/2 Minutes on What to Expect Aug 15, 2018

Show notes

Welcome to the 5th annual Mobile in Clinical Trials podcast. In this quick fire podcast, you will get a brief overview on what to expect. The conference takes place in Boston on Sept 24th, the day before DPharm. It is researched and produced by the Conference Forum and is chaired by: Daniel Karlin, MD Assistant Professor of Psychiatry, Tufts University and Former Head of Clinical, Informatics, and Regulatory Strategy, Digital Medicine, Pfizer Inc Mobile and digital tools are the future of clinical trials and as the industry continues to transition into a data science industry with a responsibility to reduce patient burden, it is really important that we bring this conference to you to get the latest examples on what tools are available and who has used them and what are the lessons to engage patients? For more information, visit www.theconferenceforum.org Producers: Valerie Bowling, Executive Director, the Conference Forum and Jennifer Moran, Producer, the Conference Forum

What to Expect at Rational Combinations 360° 2018 - 5 Min Overview Jul 19, 2018

Show notes

Rational Combinations 360° addresses business aspects, clinical advancements and scientific data in IO combination strategies. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient’s immune system to eradicate cancer. Rational Combinations 360° addresses the following plenary topics over the course of 2 days: Discovery and Preclinical ScienceTranslational Science and Emerging BiomarkersOperationalizing IO CombinationsEmerging Clinical CombinationsEmerging Data Combinations in Clinical TrialsBusiness Aspects Dr Patrick Hwu, MD Anderson, Dr Axel Hoos, GSK and Dr Ian McCaffery, Janssen, together led the design of the 3rd annual program that includes more than 45 speakers and over 30 talks. For more information about Rational Combinations 360°, visit, www.theconferenceforum.org. Be sure to use code TEML for a 10% discount. Thanks for listening.

How to Innovate in the Drug Delivery Space Jun 23, 2018

Show notes

How to Innovate in the Drug Delivery Space What does the innovation process look likeThe barrier to the innovation process and how to overcomethemSummary of disease spaceGood design and engineering practicesHow to salvage something that goes wrong?How do you find the unknown unknowns?Does it feel right? Uri Baruch Head of Drug Delivery, Cambridge Design Partnership This talk was given at the 2018 Drug Delivery West Meeting.

Key Trends in Drug Delivery: Expert Perspective Jun 23, 2018

Show notes

Opening talk at Drug Delivery West, 2018 Key Trends in Drug Delivery: Expert Perspective Randall Mrsny, PhD Professor's Chair, Department of Pharmacy and Pharmacology, University of Bath

How FARA and Horizon Pharma Partnered to Improve Clinical Development Jun 22, 2018

Show notes

Patients as Partners Day 2 Session How FARA and Horizon Pharma Partnered to Improve Clinical Development and Trial Design-Case Study This session will feature how the Friedreich’s Ataxia Research Foundation collaborated with Horizon Pharma on aspects of clinical development and trial design to better understand patients living with the disease and how to better develop medicine to help manage their disease. Key areas of discussion include how they collaborated on the following: • Focus groups to better understand drug administration • Clinical trial design to ensure feasibility and efficiency • Recruiting patients for clinical trials • Open discussion at FDA meetings Kyle Bryant Director of the Bicycle Ride Fundraiser, rideAtaxia for the Friedreich’s Ataxia Research Alliance (FARA) Robert Metz SVP, Global Business Operations and External Affairs, Horizon Pharma

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected